Application Note Modernized Impurity Analysis of the Kinase Inhibitor Imatinib by High-Resolution LC With MS-Compatible Mobile Phases

Applications | 2021 | WatersInstrumentation
Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Structural Elucidation of Unknown Impurities in the Kinase Inhibitor Imatinib Using UHPLC and High-Resolution Mass Spectrometry
Using the Systematic Screening Protocol and MaxPeak™ Premier Columns to Separate Seven Janus Kinase Inhibitors
A Systematic Approach Towards UPLC® Method Development
UPLC COLUMNS AND CONSUMABLES
UPLC COLUMNS AND CONSUMABLES
2014|Waters|Brochures and specifications